Medical software Congenica COVID-19™

clinicalfor researchanalysis

Understand the host genetics of COVID-19 For researchers investigating COVID-19, the Congenica COVID-19 module enables you to target the genomic factors related to host response with a high-degree of confidence, while saving hundreds of hours of literature review and gene analysis. Lead the COVID-19 research effort The rapid generation of new data and diverse lines of inquiry can complicate which genes to focus on when researching COVID-19 host response. The COVID-19 module within the Congenica Clinical Decision Support platform focuses on the genetic underpinnings of COVID-19 infection using curated gene panels relevant for SARS-CoV-2 infection and the latest findings from the growing scientific literature, enabling you to identify the causes, progression, treatment and prevention of COVID-19. Fast-track your research Powering analysis with Congenica COVID-19 accelerates research of individual genomic variation and virus susceptibility, severity, and clinical outcomes. The module automatically directs you to variants in relevant genes and facilitates flexible analysis of additional genes through gene searches, expert curated custom gene panels, and existing gene panels such as the PanelApp COVID-19 Research Panel, to include a broader set of potentially related genes for research. Perform evidence-based analysis Congenica COVID-19 highlights literature providing data from the latest research including the EMBI COVID-19 data portal, GENCODE and coronavirus literature searches, supporting you with up-to-date evidence of gene association with coronaviruses including SARS-CoV-2 and variants potentially associated with COVID-19 susceptibility or severity.